Deferred Tax Assets, Operating Loss Carryforwards of BIO-TECHNE Corp from 30 Jun 2014 to 30 Jun 2025

Taxonomy & unit
us-gaap: USD
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
Summary
BIO-TECHNE Corp quarterly Deferred Tax Assets, Operating Loss Carryforwards in USD history and change rate from 30 Jun 2014 to 30 Jun 2025.
  • BIO-TECHNE Corp Deferred Tax Assets, Operating Loss Carryforwards for the quarter ending 30 Jun 2025 was $26,758,000, a 6.8% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Operating Loss Carryforwards, Quarterly (USD)
Deferred Tax Assets, Operating Loss Carryforwards, YoY Quarterly Change (%)

BIO-TECHNE Corp Quarterly Deferred Tax Assets, Operating Loss Carryforwards (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $26,758,000 +$1,693,000 +6.8% 30 Jun 2025 10-K 22 Aug 2025 2025 FY
Q2 2024 $25,065,000 +$4,750,000 +23% 30 Jun 2024 10-K 22 Aug 2025 2025 FY
Q2 2023 $20,315,000 -$7,633,000 -27% 30 Jun 2023 10-K 22 Aug 2024 2024 FY
Q2 2022 $27,948,000 -$3,397,000 -11% 30 Jun 2022 10-K 23 Aug 2023 2023 FY
Q2 2021 $31,345,000 +$5,638,000 +22% 30 Jun 2021 10-K 24 Aug 2022 2022 FY
Q2 2020 $25,707,000 -$7,587,000 -23% 30 Jun 2020 10-K 25 Aug 2021 2021 FY
Q2 2019 $33,294,000 +$17,356,000 +109% 30 Jun 2019 10-K 26 Aug 2020 2020 FY
Q2 2018 $15,938,000 -$8,679,000 -35% 30 Jun 2018 10-K/A 06 Nov 2019 2019 FY
Q2 2017 $24,617,000 -$1,939,000 -7.3% 30 Jun 2017 10-K 27 Aug 2018 2018 FY
Q2 2016 $26,556,000 -$8,211,000 -24% 30 Jun 2016 10-K 07 Sep 2017 2017 FY
Q2 2015 $34,767,000 +$34,767,000 30 Jun 2015 10-K 29 Aug 2016 2016 FY
Q2 2014 $0 30 Jun 2014 10-K 31 Aug 2015 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.